BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24247169)

  • 1. Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine.
    Peroni E; Vigone MC; Mora S; Bassi LA; Pozzi C; Passoni A; Weber G
    Horm Res Paediatr; 2014; 81(1):50-4. PubMed ID: 24247169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of congenital hypothyroidism: comparison between L-thyroxine oral solution and tablet formulations up to 3 years of age.
    Vigone MC; Ortolano R; Vincenzi G; Pozzi C; Ratti M; Assirelli V; Vissani S; Cavarzere P; Mussa A; Gastaldi R; Di Mase R; Salerno M; Street ME; Trombatore J; Weber G; Cassio A
    Eur J Endocrinol; 2021 Nov; 186(1):45-52. PubMed ID: 34714772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism.
    Cassio A; Monti S; Rizzello A; Bettocchi I; Baronio F; D'Addabbo G; Bal MO; Balsamo A
    J Pediatr; 2013 Jun; 162(6):1264-9, 1269.e1-2. PubMed ID: 23312689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth.
    Jones JH; Gellén B; Paterson WF; Beaton S; Donaldson MD
    Arch Dis Child; 2008 Nov; 93(11):940-4. PubMed ID: 18456702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-inferiority of liquid thyroxine in comparison to tablets formulation in the treatment of children with congenital hypothyroidism.
    Tzifi F; Iliadi A; Voutetakis A; Platis D; Girginoudis P; Kanaka-Gantenbein C
    J Pediatr Endocrinol Metab; 2022 Feb; 35(2):239-247. PubMed ID: 34653328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
    Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
    Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism.
    Bakker B; Kempers MJ; De Vijlder JJ; Van Tijn DA; Wiedijk BM; Van Bruggen M; Vulsma T
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):529-37. PubMed ID: 12354136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
    Fallahi P; Ferrari SM; Antonelli A
    Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
    Salerno M; Militerni R; Bravaccio C; Micillo M; Capalbo D; Di MS; Tenore A
    Thyroid; 2002 Jan; 12(1):45-52. PubMed ID: 11838730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel therapeutic paradigm to treat congenital hypothyroidism.
    Mathai S; Cutfield WS; Gunn AJ; Webster D; Jefferies C; Robinson E; Hofman P
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):142-7. PubMed ID: 18598275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
    Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
    J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial.
    Uchiyama A; Kushima R; Watanabe T; Kusuda S
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):177-82. PubMed ID: 25153575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital hypothyroidism. Therapeutic strategy at the early stage of treatment].
    Touati G; Léger J; Czernichow P
    Arch Fr Pediatr; 1991; 48(7):461-5. PubMed ID: 1929745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T4 plus T3 treatment in children with hypothyroidism and inappropriately elevated thyroid-stimulating hormone despite euthyroidism on T4 treatment.
    Akcay T; Turan S; Guran T; Unluguzel G; Haklar G; Bereket A
    Horm Res Paediatr; 2010; 73(2):108-14. PubMed ID: 20190547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
    Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
    Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
    Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
    Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In congenital hypothyroidism, an initial L-thyroxine dose of 10-12 μg/kg/day is sufficient and sometimes excessive based on thyroid tests 1 month later.
    Vaidyanathan P; Pathak M; Kaplowitz PB
    J Pediatr Endocrinol Metab; 2012; 25(9-10):849-52. PubMed ID: 23426811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of transient hypothyroidism in patients diagnosed with congenital hypothyroidism.
    Peltek Kendirci HN; Aycan Z; Sağsak E; Keskin M; Çetinkaya S
    Turk J Med Sci; 2015; 45(4):745-50. PubMed ID: 26422840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis on factors affecting suppression of thyroid-stimulating hormone in treated congenital hypothyroidism.
    Ng SM; Wong SC; Isherwood DM; Smith CS; Didi M
    Horm Res; 2004; 62(5):245-51. PubMed ID: 15499223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison Among Two Liquid Formulations of L-thyroxine in the Treatment of Congenital Hypothyroidism in the First Month of Life: A Pilot Study.
    Tuli G; Munarin J; de Sanctis L
    Front Endocrinol (Lausanne); 2022; 13():860775. PubMed ID: 35480479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.